Classification of Alzheimer's Disease Using the Convolutional Neural Network (CNN) with Transfer Learning and Weighted Loss

  title={Classification of Alzheimer's Disease Using the Convolutional Neural Network (CNN) with Transfer Learning and Weighted Loss},
  author={Muhammad W. Oktavian and Novanto Yudistira and Achmad Ridok},
Alzheimer’s disease is a progressive neurodegenerative disorder that gradually deprives the patient of cognitive function and can end in death. With the advancement of technology today, it is possible to detect Alzheimer’s disease through Magnetic Resonance Imaging (MRI) scans. So that MRI is the technique most often used for the diagnosis and analysis of the progress of Alzheimer’s disease. With this technology, image recognition in the early diagnosis of Alzheimer’s disease can be achieved… 

Figures and Tables from this paper



Towards Alzheimer's disease classification through transfer learning

  • Marcia HonN. Khan
  • Computer Science
    2017 IEEE International Conference on Bioinformatics and Biomedicine (BIBM)
  • 2017
This paper attempts solving issues with transfer learning, where state-of-the-art architectures such as VGG and Inception are initialized with pre-trained weights from large benchmark datasets consisting of natural images, and the fully-connected layer is re-trained with only a small number of MRI images.

Alzheimer Disease Classification Using Transfer Learning

In recent years, transfer learning has gained huge popularity in solving problems from various fields including the medical image analysis. Clinical picture examination has altered medical services

Multi instance learning via deep CNN for multi-class recognition of Alzheimer's disease

The results indicated that the proposed multi-instance learning (MIL) learns region of interest (ROI) itself and thus that could help to efficiently identify the precise patterns for AD.

Classification of Alzheimer Disease on Imaging Modalities with Deep CNNs Using Cross-Modal Transfer Learning

This work proposes a method of a cross-modal transfer learning: from Structural MRI to Diffusion Tensor Imaging modality that shows a reduction of the over-fitting phenomena, improves learning performance, and thus increases the accuracy of prediction.

Prediction and classification of Alzheimer disease based on quantification of MRI deformation

A machine learning method to discriminate patients with AD or mild cognitive impairment (MCI) from healthy elderly and to predict the AD conversion in MCI patients by computing and analyzing the regional morphological differences of brain between groups is proposed.

Automated Detection of Alzheimer Disease Using Region Growing technique and Artificial Neural Network

This paper proposed a fusion method to distinguish between the normal and (AD) MRIs and the robust of the developed method can be considered effectively to diagnose and determine the type of AD image.

Improving Alzheimer's Disease Diagnosis with Machine Learning Techniques

A quantitative EEG (qEEG) processing method for automatic differentiation of patients with AD from normal individuals, as a complement to the diagnosis of probable dementia, is developed.

Residual and plain convolutional neural networks for 3D brain MRI classification

The performance of the proposed approach for classification of Alzheimer's disease versus mild cognitive impairment and normal controls on the Alzheimers Disease National Initiative dataset of 3D structural MRI brain scans is demonstrated.

Analyzing Lung Disease Using Highly Effective Deep Learning Techniques

This experiment used 5810 images for training and validation with the MobileNet, Densenet-121 and Resnet-50 models, which are popular networks used to classify the accuracy of images, and utilized a rotational technique to adjust the lung disease dataset to support learning with these convolutional neural network models.

The clinical use of structural MRI in Alzheimer disease

The utility of structural imaging and other markers will be increased by standardization of acquisition and analysis methods, and by development of robust algorithms for automated assessment, as well as by research into other imaging and nonimaging markers.